FDA Inspection
AGC Biologics, Inc.AGC Biologics, Inc. – FDA Inspection, Mar 27, 2024
Record Details
This FDA Inspection record concerns AGC Biologics, Inc., with an inspection on March 27, 2024, issued by the Seattle District Office, covering human drugs.
View Company Profile
ID · c82be910-e28a-4ee7-a190-b28bd65abc66
Inspection Facts
- Inspection number
- 1231895
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AGC Biologics, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2025 | Not classified | Seattle District Office | |
| February 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 15, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 20, 2017 | Not classified | Seattle District Office |
Other documents for AGC Biologics, Inc.
- FDA Inspection 1265749 - 2025-04-18
- FDA Inspection 1197098 - 2023-02-10
- FDA Inspection 1149254 - 2021-07-23
- FDA Inspection 1109813 - 2018-10-15
- FDA Inspection 1016289 - 2017-04-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.